Aiello A, Najafi-Fard S and Goletti D 2023 Initial immune response after exposure to Mycobacterium tuberculosis or to SARS-COV-2: similarities and differences. Front. Immunol. 14 1244556

Article  CAS  PubMed  PubMed Central  Google Scholar 

Al-Kayali RS, Kashkash MF, Alhussein Alhajji AH, et al. 2023 Activation of tuberculosis in recovered COVID-19 patients: a case report. Ann. Med. Surg. 85 280–283

Article  Google Scholar 

Batra S, Nair AG and Syal K 2023 An unusual presentation of superior mesenteric venous occlusion in mild COVID-19. Indian J. Clin. Biochem. 38 275–278

Article  CAS  PubMed  Google Scholar 

Booysen P, Wilkinson KA, Sheerin D, et al. 2023 Immune interaction between SARS-COV-2 and Mycobacterium tuberculosis. Front. Immunol. 14 1254206

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bostanghadiri N, Jazi FM, Razavi S, et al. 2021 Mycobacterium tuberculosis and SARS-COV-2 coinfections: a review. Front. Microbiol. 12 747827

Article  PubMed  Google Scholar 

Brites D and Gagneux S 2015 Co-evolution of Mycobacterium tuberculosis and Homo sapiens. Immunol. Rev. 264 6–24

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cascella M, Rajnik M, Aleem A, et al. 2024. Features, evaluation, and treatment of coronavirus (COVID-19); in Statpearls (StatPearls Publishing LLC)

Casco N, Jorge AL, Palmero DJ, et al. 2023 Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort. Eur. Respir. J. 62 5

Google Scholar 

Cavalcanti YV, Brelaz MC, Neves JK, et al. 2012 Role of TNF-alpha, IFN-gamma, and IL-10 in the development of pulmonary tuberculosis. Pulm. Med. 2012 745483

Article  PubMed  PubMed Central  Google Scholar 

Chan KF, Ting-Fung M, Sridhar S, et al. 2024 Changes in the incidence, clinical features and outcomes of tuberculosis during COVID-19 pandemic. J. Infect. Public Health 17 102511

Article  PubMed  Google Scholar 

Chiok KR, Dhar N and Banerjee A 2023 Mycobacterium tuberculosis and SARS-COV-2 co-infections: the knowns and unknowns. iScience 26 106629

Christine T, Tarigan AP and Ananda FR 2019 The correlation between levels of transforming growth factor-β with pulmonary fibrosis in post pulmonary tuberculosis in Medan, North Sumatera – Indonesia. Open Access Maced. J. Med. Sci. 7 2075–2078

Article  PubMed  PubMed Central  Google Scholar 

Chugh S, Bahal RK, Dhiman R, et al. 2024 Antigen identification strategies and preclinical evaluation models for advancing tuberculosis vaccine development. NPJ Vaccines 9 57

Article  PubMed  PubMed Central  Google Scholar 

Conway Morris A and Tong A 2022 Novel treatments and trials in COVID-19 (Elsevier) 109–120

Cox V, Wilkinson L, Grimsrud A, et al. 2020 Critical changes to services for tb patients during the COVID-19 pandemic. Int. J. Tuberc. Lung Dis. 24 542–544

Article  CAS  PubMed  Google Scholar 

Cremoni M, Allouche J, Graça D, et al. 2022 Low baseline IFN-γ response could predict hospitalization in COVID-19 patients. Front. Immunol. 13 953502

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dara M, Sotgiu G, Reichler MR, et al. 2020 New diseases and old threats: lessons from tuberculosis for the COVID-19 response. Int. J. Tuberc. Lung Dis. 24 544–545

Article  CAS  PubMed  Google Scholar 

Detelich JF and Kempker JA 2023 Respiratory infections. Clin. Chest Med. 44 509–517

Article  PubMed  Google Scholar 

Deveci F, Akbulut HH, Turgut T, et al. 2005 Changes in serum cytokine levels in active tuberculosis with treatment. Mediators Inflamm. 2005 256–262

Dorman SE, Uzel G, Roesler J, et al. 1999 Viral infections in interferon-gamma receptor deficiency. J. Pediatr. 135 640–643

Article  CAS  PubMed  PubMed Central  Google Scholar 

Falzon D, Zignol M, Bastard M, et al. 2023 The impact of the COVID-19 pandemic on the global tuberculosis epidemic. Front. Immunol. 14 1234785

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ferreira-Gomes M, Kruglov A, Durek P, et al. 2021 SARS-COV-2 in severe COVID-19 induces a TGF-β-dominated chronic immune response that does not target itself. Nat. Commun. 12 1961

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao Y, Liu M, Chen Y, et al. 2021 Association between tuberculosis and COVID-19 severity and mortality: a rapid systematic review and meta-analysis. J. Med. Virol. 93 194–196

Article  CAS  PubMed  Google Scholar 

Goletti D, Al-Abri S, Migliori GB, et al. 2023 World tuberculosis day 2023 theme “Yes! We Can End TB!” Int. J. Infect. Dis. 130 S1–S3

Article  PubMed  Google Scholar 

Gong W, Mao Y, Li Y, et al. 2022 BCG vaccination: a potential tool against COVID-19 and COVID-19-like black swan incidents. Int. Immunopharmacol. 108 108870

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gubernatorova EO, Gorshkova EA, Polinova AI, et al. 2020 Il-6: relevance for immunopathology of SARS-COV-2. Cytokine Growth Factor Rev. 53 13–24

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gupte AN, Kumar P, Araújo-Pereira M, et al. 2022 Baseline il-6 is a biomarker for unfavourable tuberculosis treatment outcomes: a multisite discovery and validation study. Eur. Respir. J. 59 4

Article  Google Scholar 

He S, Liu W, Jiang M, et al. 2021 Clinical characteristics of COVID-19 patients with clinically diagnosed bacterial co-infection: a multi-center study. PloS One 16 e0249668

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jacobs M, Togbe D, Fremond C, et al. 2007 Tumor necrosis factor is critical to control tuberculosis infection. Microbes Infect. 9 623–628

Article  CAS  PubMed  Google Scholar 

Jirjees FJ, Dallal Bashi YH and Al-Obaidi HJ 2021 COVID-19 death and BCG vaccination programs worldwide. Tuberc. Respir. Dis. 84 13–21

Article  Google Scholar 

Kessel B, Heinsohn T, Ott JJ, et al. 2023 Impact of COVID-19 pandemic and anti-pandemic measures on tuberculosis, viral hepatitis, HIV/AIDS and malaria-a systematic review. PLS Glob. Public Health 3 e0001018

Article  PubMed  PubMed Central  Google Scholar 

Krishna BA, Lim EY, Metaxaki M, et al. 2024 Spontaneous, persistent, T cell-dependent IFN-γ release in patients who progress to long covid. Sci. Adv. 10 eadi9379

Kuhtreiber WM, Hostetter ER, Wolfe GE, et al. 2024 Late in the us pandemic, multi-dose BCG vaccines protect against COVID-19 and infectious diseases. iScience 27 109881

Losier A, Gupta G, Caldararo M, et al. 2023 The impact of coronavirus disease 2019 on viral, bacterial, and fungal respiratory infections. Clin. Chest Med. 44 407–423

Article  PubMed  PubMed Central  Google Scholar 

Maiti K, Syal K, Chatterji D, et al. 2017 Synthetic arabinomannan heptasaccharide glycolipids inhibit biofilm growth and augment isoniazid effects in Mycobacterium smegmatis. Chembiochem 18 1959–1970

Article  CAS  PubMed  Google Scholar 

Mannan S, Oga-Omenka C, Soman Thekkepurakkal A, et al. 2022 Adaptations to the first wave of the COVID-19 pandemic by private sector tuberculosis care providers in India. J. Clin. Tuberc. Other Mycobact. Dis. 28 100327

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mcquaid CF, Mccreesh N, Read JM, et al. 2020 The potential impact of COVID-19-related disruption on tuberculosis burden. Eur. Respir. J. 56 2

Article  Google Scholar 

Mcquaid CF, Vassall A, Cohen T, et al. 2021 The impact of COVID-19 on TB: a review of the data. Int. J. Tuberc. Lung Dis. 25 436–446